| Literature DB >> 24286577 |
David Y Zhang1, Allen S Anderson.
Abstract
Heart failure (HF) is a syndrome characterized by upregulation of the sympathetic nervous system and abnormal responsiveness of the parasympathetic nervous system. Studies in the 1980s and 1990s demonstrated that inhibition of the renin-angiotensin-aldosterone system with angiotensin-converting enzyme inhibitors improved symptoms and mortality in HF resulting from systolic dysfunction, thus providing a framework to consider the use of β-blockers for HF therapy, contrary to the prevailing wisdom of the time. Against this backdrop, this article reviews the contemporary understanding of the sympathetic nervous system and the failing heart.Entities:
Keywords: Heart failure; Neurohormone; Renin-angiotensin-aldosterone; Sympathetic nervous system
Mesh:
Substances:
Year: 2014 PMID: 24286577 PMCID: PMC5873965 DOI: 10.1016/j.ccl.2013.09.010
Source DB: PubMed Journal: Cardiol Clin ISSN: 0733-8651 Impact factor: 2.213